20-Hydroxyeicosatetraenoic acid contributes to the inhibition of K+ channel activity and vasoconstrictor response to angiotensin II in rat renal microvessels

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Fan, Fan ^a   Sun, Cheng Wen ^b   Maier, Kristopher G ^c   Williams, Jan M ^a   Pabbidi, Malikarjuna R ^a   Didion, Sean P ^a   Falck, John R ^d   Zhuo, Jialong ^a   Roman, Richard J ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b NORTH DAKOTA STATE UNIVERSITY   (United States)

^c SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

20 HYDROXYICOSATETRAENOIC ACID; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; CALCIUM ION; LARGE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL DIAMETER; BLOOD VESSEL TONE; CALCIUM CELL LEVEL; CONTROLLED STUDY; FATTY ACID SYNTHESIS; HORMONE ACTION; KIDNEY BLOOD VESSEL; MALE; MICROVASCULATURE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION;

ANGIOTENSIN II; ANIMALS; CALCIUM; GENE EXPRESSION; HYDROXYEICOSATETRAENOIC ACIDS; IONOMYCIN; MALE; MICROVESSELS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PHOSPHOLIPASES A2; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; POTASSIUM CHANNELS, CALCIUM-ACTIVATED; RATS; RECEPTORS, ANGIOTENSIN; RENAL CIRCULATION; TYPE C PHOSPHOLIPASES; VASOCONSTRICTOR AGENTS;

EID: 84891768098     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0082482     Document Type: Article

References (43)

1. Alonso-Galicia M, Maier KG, Greene AS, Cowley AW Jr., Roman RJ (2002) Role of 20-hydroxyeicosatetraenoic acid in the renal and vasoconstrictor actions of angiotensin II. Am J Physiol Regul Integr Comp Physiol 283: R60-R68. PubMed: 12069931.
2. Kohagura K, Arima S, Endo Y, Chiba Y, Ito O et al. (2001) Involvement of cytochrome P450 metabolites in the vascular action of angiotensin II on the afferent arterioles. Hypertens Res 24: 551-557. doi:10.1291/hypres.24.551. PubMed: 11675950.
3. Imig JD, Zou AP, Ortiz de Montellano PR, Sui Z, Roman RJ (1994) Cytochrome P-450 inhibitors alter afferent arteriolar responses to elevations in pressure. Am J Physiol 266: H1879-H1885. PubMed: 8203587.
4. Croft KD, McGiff JC, Sanchez-Mendoza A, Carroll MA (2000) Angiotensin II releases 20-HETE from rat renal microvessels. Am J Physiol Renal Physiol 279: F544-F551. PubMed: 10966934.
5. Chu ZM, Croft KD, Kingsbury DA, Falck JR, Reddy KM et al. (2000) Cytochrome P450 metabolites of arachidonic acid may be important mediators in angiotensin II-induced vasoconstriction in the rat mesentery in vivo. Clin Sci (Lond) 98: 277-282. doi:10.1042/CS19990217. PubMed: 10677385.
6. Parmentier JH, Muthalif MM, Nishimoto AT, Malik KU (2001) 20-Hydroxyeicosatetraenoic acid mediates angiotensin ii-induced phospholipase d activation in vascular smooth muscle cells. Hypertension 37: 623-629. doi:10.1161/01.HYP.37.2.623. PubMed: 11230346.
7. Roman RJ (2002) P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev 82: 131-185. PubMed: 11773611.
8. Imig JD, Deichmann PC (1997) Afferent arteriolar responses to ANG II involve activation of PLA2 and modulation by lipoxygenase and P-450 pathways. Am J Physiol 273: F274-F282. PubMed: 9277588.
9. Dunn KM, Renic M, Flasch AK, Harder DR, Falck J et al. (2008) Elevated production of 20-HETE in the cerebral vasculature contributes to severity of ischemic stroke and oxidative stress in spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 295: H2455-H2465. doi:10.1152/ajpheart.00512.2008. PubMed: 18952718.
10. Harder DR, Narayanan J, Birks EK, Liard JF, Imig JD et al. (1996) Identification of a putative microvascular oxygen sensor. Circ Res 79: 54-61. doi:10.1161/01.RES.79.1.54. PubMed: 8925569.
11. 2 distribution in the living tissue. Kidney Int 51: 372-380. doi:10.1038/ki. 1997.49. PubMed: 9027709.
12. Ito O, Roman RJ (1999) Regulation of P-450 4A activity in the glomerulus of the rat. Am J Physiol 276: R1749-R1757. PubMed: 10362756.
13. Imig JD, Zou AP, Stec DE, Harder DR, Falck JR et al. (1996) Formation and actions of 20-hydroxyeicosatetraenoic acid in rat renal arterioles. Am J Physiol 270: R217-R227. PubMed: 8769805.
14. Guo DF, Inagami T (1994) The genomic organization of the rat angiotensin II receptor AT1B. Biochim Biophys Acta 1218: 91-94. doi:10.1016/0167-4781(94) 90105-8. PubMed: 8193170.
15. Koike G, Horiuchi M, Yamada T, Szpirer C, Jacob HJ et al. (1994) Human type 2 angiotensin II receptor gene: cloned, mapped to the X chromosome, and its mRNA is expressed in the human lung. Biochem Biophys Res Commun 203: 1842-1850. doi:10.1006/bbrc.1994.2402. PubMed: 7945336.
16. Juncos LA, Ito S, Carretero OA, Garvin JL (1994) Removal of endothelium-dependent relaxation by antibody and complement in afferent arterioles. Hypertension 23: I54-I59. doi:10.1161/01.HYP.23.1-Suppl.I54. PubMed: 8282376.
17. Ma YH, Gebremedhin D, Schwartzman ML, Falck JR, Clark JE et al. (1993) 20-Hydroxyeicosatetraenoic acid is an endogenous vasoconstrictor of canine renal arcuate arteries. Circ Res 72: 126-136. doi:10.1161/01.RES.72.1.126. PubMed: 8417836.
18. Alonso-Galicia M, Hudetz AG, Shen H, Harder DR, Roman RJ (1999) Contribution of 20-HETE to vasodilator actions of nitric oxide in the cerebral microcirculation. Stroke 30: 2727-2734; discussion: 10.1161/01.STR.30.12.2727. PubMed: 10583004.
19. Sun CW, Falck JR, Harder DR, Roman RJ (1999) Role of tyrosine kinase and PKC in the vasoconstrictor response to 20-HETE in renal arterioles. Hypertension 33: 414-418. doi:10.1161/01.HYP.33.1.414. PubMed: 9931139.
20. Alonso-Galicia M, Falck JR, Reddy KM, Roman RJ (1999) 20-HETE agonists and antagonists in the renal circulation. Am J Physiol 277: F790-F796. PubMed: 10564244.
21. Zanetta L, Marcus SG, Vasile J, Dobryansky M, Cohen H et al. (2000) Expression of Von Willebrand factor, an endothelial cell marker, is upregulated by angiogenesis factors: a potential method for objective assessment of tumor angiogenesis. Int J Cancer 85: 281-288. doi:10.1002/(SICI)1097-0215(20000115)85: 2. PubMed: 10629090.
22. Horvath B, Hegedus D, Szapary L, Marton Z, Alexy T et al. (2004) Measurement of von Willebrand factor as the marker of endothelial dysfunction in vascular diseases. Exp Clin Cardiol 9: 31-34. PubMed: 19641694.
23. Akishita M, Ito M, Lehtonen JY, Daviet L, Dzau VJ et al. (1999) Expression of the AT2 receptor developmentally programs extracellular signal-regulated kinase activity and influences fetal vascular growth. J Clin Invest 103: 63-71. doi:10.1172/JCI5182. PubMed: 9884335.
24. Kim S, Iwao H (2000) Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev 52: 11-34. PubMed: 10699153.
25. Mifune M, Sasamura H, Shimizu-Hirota R, Miyazaki H, Saruta T (2000) Angiotensin II type 2 receptors stimulate collagen synthesis in cultured vascular smooth muscle cells. Hypertension 36: 845-850. doi:10.1161/01.HYP.36.5. 845. PubMed: 11082154.
26. Zou AP, Ma YH, Sui ZH, Ortiz de Montellano PR, Clark JE et al. (1994) Effects of 17-octadecynoic acid, a suicide-substrate inhibitor of cytochrome P450 fatty acid omega-hydroxylase, on renal function in rats. J Pharmacol Exp Ther 268: 474-481. PubMed: 8301590.
27. Ortiz de Montellano PR, Reich NO (1984) Specific inactivation of hepatic fatty acid hydroxylases by acetylenic fatty acids. J Biol Chem 259: 4136-4141. PubMed: 6706995.
28. Miyata N, Taniguchi K, Seki T, Ishimoto T, Sato-Watanabe M et al. (2001) HET0016, a potent and selective inhibitor of 20-HETE synthesizing enzyme. Br J Pharmacol 133: 325-329. doi:10.1038/sj.bjp.0704101. PubMed: 11375247.
29. Sadoshima J (1998) Versatility of the angiotensin II type 1 receptor. Circ Res 82: 1352-1355. doi:10.1161/01.RES.82.12.1352. PubMed: 9648733.
30. Roman RJ, Alonso-Galicia M (1999) P-450 Eicosanoids: A Novel Signaling Pathway Regulating. Renal Function - News Physiol Sci 14: 238-242.
31. Zou AP, Fleming JT, Falck JR, Jacobs ER, Gebremedhin D et al. (1996) 20-HETE is an endogenous inhibitor of the large-conductance Ca(2+)-activated K+ channel in renal arterioles. Am J Physiol 270: R228-R237. PubMed: 8769806.
32. Kaley G (2000) Regulation of vascular tone: role of 20-HETE in the modulation of myogenic reactivity. Circ Res 87: 4-5. doi:10.1161/01.RES.87.1.4. PubMed: 10884363.
33. Boulay G, Servant G, Luong TT, Escher E, Guillemette G (1992) Modulation of angiotensin II binding affinity by allosteric interaction of polyvinyl sulfate with an intracellular domain of the DuP-753-sensitive angiotensin II receptor of bovine adrenal glomerulosa. Mol Pharmacol 41: 809-815. PubMed: 1569928.
34. Imig JD (2013) Epoxyeicosatrienoic acids, 20-hydroxyeicosatetraenoic acid, and renal microvascular function. Prostaglandins Other Lipid Mediat, 104-105: 2-7. PubMed: 23333581.
35. Roman RJ, Maier KG, Sun CW, Harder DR, Alonso-Galicia M (2000) Renal and cardiovascular actions of 20-hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids. Clin Exp Pharmacol Physiol 27: 855-865. doi:10.1046/j.1440-1681.2000.03349.x. PubMed: 11071299.
36. Harder DR, Lange AR, Gebremedhin D, Birks EK, Roman RJ (1997) Cytochrome P450 metabolites of arachidonic acid as intracellular signaling molecules in vascular tissue. J Vasc Res 34: 237-243. doi:10.1159/000159228. PubMed: 9226306.
37. Fellner SK, Arendshorst WJ (2005) Angiotensin II Ca2+ signaling in rat afferent arterioles: stimulation of cyclic ADP ribose and IP3 pathways. Am J Physiol Renal Physiol 288: F785-F791. PubMed: 15598842.
38. Inscho EW, Imig JD, Cook AK (1997) Afferent and efferent arteriolar vasoconstriction to angiotensin II and norepinephrine involves release of Ca2+ from intracellular stores. Hypertension 29: 222-227. doi:10.1161/01.HYP.29.1. 222. PubMed: 9039106.
39. Jackson WF (2000) Ion channels and vascular tone. Hypertension 35: 173-178. doi:10.1161/01.HYP.35.1.173. PubMed: 10642294.
40. Nowicki S, Chen SL, Aizman O, Cheng XJ, Li D et al. (1997) 20-Hydroxyeicosa-tetraenoic acid (20 HETE) activates protein kinase C. Role in regulation of rat renal Na+,K+-ATPase. J Clin Invest 99: 1224-1230. doi:10.1172/JCI119279. PubMed: 9077530.
41. Amlal H, LeGoff C, Vernimmen C, Soleimani M, Paillard M et al. (1998) ANG II controls Na(+)-K+(NH4+)-2Cl- cotransport via 20-HETE and PKC in medullary thick ascending limb. Am J Physiol 274: C1047-C1056. PubMed: 9575802.
42. Cheng J, Wu CC, Gotlinger KH, Zhang F, Falck JR et al. (2010) 20-hydroxy-5,8,11,14-eicosatetraenoic acid mediates endothelial dysfunction via IkappaB kinase-dependent endothelial nitric-oxide synthase uncoupling. J Pharmacol Exp Ther 332: 57-65. doi:10.1124/jpet.109.159863. PubMed: 19841472.
43. Randriamboavonjy V, Busse R, Fleming I (2003) 20-HETE-induced contraction of small coronary arteries depends on the activation of Rhokinase. Hypertension 41: 801-806. doi:10.1161/01.HYP.0000047240.33861.6B. PubMed: 12623999.